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A B S T R A C T   
Olfactory hallucinations referring to olfactory perceptions in the absence of chemical stimuli, occur in non- 
clinical and clinical populations. Few studies have investigated their prevalence in the general population and 
little is known about factors triggering and maintaining them such as substance use, severe life events, and mood. 
We analyzed self-report data from 2500 community dwelling Norwegians, aged 18-96 years, for occurrence of 
olfactory hallucinations and co-occurring hallucinations in other modalities (auditory, visual, tactile). Analyses 
included age, sex, self-reported symptoms of depression and anxiety, mental health status, and experience of 
severe life-events. The results show that 4.2% (95% CI 3.5-5.1%) reported having experienced olfactory hallu-
cinations, and 56% of individuals experiencing olfactory hallucinations also reported these in combination with 
hallucinations in other modalities. Prevalence varied significantly in terms of age and sex, in that olfactory 
hallucinations were most frequently reported by young individuals and females. Self-reported symptoms of 
anxiety and experience of stressful life events were significantly associated with olfactory hallucinations, sug-
gesting that experiencing olfactory hallucinations may negatively affect functioning and may increase the 
likelihood of developing psychopathology. Findings underline the need to continue to examine olfactory hal-
lucinations albeit with a more comprehensive assessment in order to increase knowledge on this experience.   
1. Introduction 
Hallucinations are sensory perceptions occurring in the absence of 
corresponding sensory stimuli. Although considered a core feature of 
psychosis, studies point to their occurrence and relevance in other 
clinical groups (Aleman & Larøi, 2008) and in healthy individuals 
(Johns et al., 2014; Krakvik et al., 2015; Nuevo et al., 2012; Waters, 
Blom, Jardri, Hugdahl, & Sommer, 2018). Understanding the underlying 
mechanisms of these different types of hallucinations, as well as their 
consequences on daily life, could aid improving the lives of those 
affected (Johns, 2005; Waters et al., 2018). While auditory 
hallucinations (and to a lesser extent, visual hallucinations) have been 
frequently studied in the general population, much less is known about 
olfactory hallucinations. 
The sense of smell is increasingly recognized as an important factor 
for well-being and quality of life (Croy, Nordin, & Hummel, 2014; Miwa 
et al., 2001; Rochet, El-Hage, Richa, Kazour, & Atanasova, 2018). In the 
somatic/olfactory literature, a differentiation is commonly made be-
tween qualitative and quantitative olfactory functions. Qualitative ol-
factory dysfunctions include olfactory hallucinations, also termed 
phantosmia, referring to an odor sensation without a present stimulus (i. 
e., a person perceives the smell of an orange in the absence of any orange 
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or orange scent). Although both terms are often used interchangeably, 
some researchers differentiate between olfactory hallucinations lasting a 
few seconds and phantosmia lasting longer (D. Leopold, 2002). The 
other qualitative dysfunction is parosmia, indicating a distorted 
perception of an odor (i.e., smelling an orange evokes the perception of 
something rotten). Quantitative olfactory functions are commonly 
differentiated into sensitivity referring to the ability to detect an olfactory 
stimulus and identification referring to a person’s ability to identify an 
olfactory stimulus (Frasnelli et al., 2004). 
Prevalence rates and the association between qualitative and quan-
titative olfactory functions are still a matter of debate. One reason for 
this relates to assessment methods with objective methods only being 
available for quantitative functions, while qualitative olfactory func-
tions are exclusively based on self-reports. Additionally, both qualitative 
and quantitative self-reported functions are known to be biased. 
Although specificity for quantitative smell function has shown to be high 
in large population-based studies, indicating that individuals with a 
normal sense of smell tend to accurately report no dysfunction, sensi-
tivity is as slow as 20-30%, suggesting that individuals with an impaired 
sense of smell are unaware of the problem (Lotsch & Hummel, 2019; 
Murphy et al., 2002; Wehling, Nordin, Espeseth, Reinvang, & Lunder-
vold, 2011; Yang & Pinto, 2016). Qualitative dysfunctions have been 
shown to be overreported, at least by populations from chemosensory 
clinics (Gent, Goodspeed, Zagraniski, & Catalanotto, 1987). 
There is no objective, accurate diagnostic measure to assess olfactory 
hallucinations. Landis et al. (2010) raised the issue that standardized, 
more systematic questioning would provide meaningful scores on 
qualitative olfactory dysfunctions. So far, assessment occurs either 
during a clinical interview or as part of a questionnaire (often using a 
single item question such as “Do you sometimes experience a particular 
odor even though nothing is there?”). In the clinical setting, more details 
may emerge, and a verification may be followed up with further quali-
tative questions. Response formats in questionnaires vary from a “yes/ 
no”-format to scale-formats with endpoints like “never” to “six to seven 
times a week/always” (Bainbridge, Byrd-Clark, & Leopold, 2018; 
Ohayon, 2000). This may contribute to variation in prevalence rates. 
Studies from chemosensory clinics estimate prevalence rates of 11- 
25% for olfactory hallucinations occurring after sinonasal diseases, 
upper respiratory infections, head trauma, epilepsy, migraine/head-
ache, neurodegenerative diseases, and advancing age (Bramerson, 
Nordin, & Bende, 2007; Coleman, Grosberg, & Robbins, 2011; Landis & 
Burkhard, 2008; Landis, Konnerth, & Hummel, 2004; Nordin et al., 
1996; Reden, Maroldt, Fritz, Zahnert, & Hummel, 2007). Leopold 
(2002) describes the classic case presenting with olfactory hallucina-
tions as “a woman between 15 and 30 years of age with an episode of odor 
perception the individual thinks is real but others do not appreciate. It resolves 
spontaneously with no aftereffects” (p. 613). He describes that in the 
long-term a similar experience may occur within a month, followed by 
increasing frequency, longer duration, potentially lasting years. To date, 
duration of the actual olfactory hallucination episodes and the duration 
across lifetime is rarely systematically addressed. Regarding the former, 
Sjolund and colleagues (2017) reported olfactory hallucinations mainly 
to be fleeting (39%) or lasting a few minutes (43%). The existing lon-
gitudinal studies on olfactory hallucinations across lifetime report 
improvement/disappearance of olfactory hallucinations in 30-64% of 
cases, no change in 39-60%, and deterioration in 5-10% (Landis & 
Burkhard, 2008; Reden et al., 2007). 
In psychiatric disorders, olfactory hallucinations are reported in 
patients with depression (Croy, Yarina, & Hummel, 2013), bipolar dis-
order (Baethge et al., 2005), and schizophrenia (Langdon, McGuire, 
Stevenson, & Catts, 2011; Stevenson, Langdon, & McGuire, 2011). 
Occurrence rates range from 13-17% in depression and bipolar disorders 
to 13-35% in schizophrenic and schizoaffective disorders (Baethge et al., 
2005; Langdon et al., 2011). Compared to other modalities, olfactory 
hallucinations appear to be (one of) the least common hallucinations 
(Baethge et al., 2005; Lewandowski, DePaola, Camsari, Cohen, & Öngür, 
2009). This could be related to the fact that rating scales frequently 
group olfactory hallucinations together with somatic, tactile, or gusta-
tory hallucinations (Lim, Hoek, Deen, Blom, & Investigators, 2016). 
Langdon et al. (2011) underlined that an evidently high proportion of 
patients with schizophrenia report olfactory hallucinations when these 
are explicitly assessed. The only large scale study (n > 13000) investi-
gating associations between olfactory hallucinations and mood (anxiety, 
depression, and bipolar disorders) and adjustment disorders, reported 
associations of anxiety, bipolar, and adjustment disorders in participants 
experiencing frequent (at least once a week) and infrequent (once a 
month or less) olfactory hallucinations (Ohayon, 2000). An association 
with depression was only reported when infrequent olfactory halluci-
nations occurred. The author suggested that olfactory hallucinations 
may be triggered by psychoactive substances or medication, rather than 
being a symptom of psychiatric disorders. Longitudinal studies focusing 
on olfactory hallucinations indicate that these may help to identify 
psychosis-prone individuals within a risk group (Kwapil, Chapman, 
Chapman, & Miller, 1996), and that these hallucinations are associated 
with an earlier age of psychosis onset (Lewandowski et al., 2009), 
although this has not always been confirmed (Langdon et al., 2011). 
Studies investigating prevalence rates for olfactory hallucinations in 
the general population are scarce. The few existing population-based 
epidemiological studies report prevalence rates varying between 5- 
14.5% (Bainbridge et al., 2018; Ohayon, 2000; Rawal, Hoffman, Bain-
bridge, Huedo-Medina, & Duffy, 2016; Sjolund, Larsson, Olofsson, 
Seubert, & Laukka, 2017). In by the far largest study (Ohayon, 2000), 
the prevalence rate of 14.5% for olfactory hallucinations during daytime 
are further differentiated into frequent (at least once a week; prevalence 
rate 2.4%) and infrequent (once a month or less; prevalence rate 12.1%). 
Two recent studies reported 12-month prevalence rates between 6-6.5% 
in community-dwelling adults aged 40 years and older (Bainbridge 
et al., 2018; Rawal et al., 2016). A lower rate of 4.9% 12-month prev-
alence rate was reported in a Swedish study including individuals aged 
60-90 years (Sjolund et al., 2017). 
These epidemiologic studies consistently show that olfactory hallu-
cinations occurred more often in women (Bainbridge et al., 2018; 
Ohayon, 2000; Sjolund et al., 2017). Other sociodemographic and so-
matic factors that are associated with a higher prevalence of olfactory 
hallucinations are younger age (< 40 years), low socio-economic status, 
poor self-reported health status/cardiovascular risk, head injury, and 
persistent dry mouth symptom (Bainbridge et al., 2018; Sjolund et al., 
2017). Factors such as ethnicity, education, smoking, and alcohol use 
were not clearly associated with olfactory hallucinations. 
Despite the above findings, the prevalence of olfactory hallucinations 
and associated factors are still under-researched. Replications in large 
population-based samples including factors known to be associated with 
hallucinations in other modalities, are needed. Linscott and van Os 
(2013) summarized that psychotic-like experiences (including halluci-
nations) are highest in young individuals (below the age of 40 years), 
with low education, who have been exposed to alcohol and drugs, and 
who have experienced stressful and traumatic events. 
The primary aim of this study was to investigate the prevalence of 
olfactory hallucinations in a large Norwegian population-based sample 
that included a wide age-range (18-96 years). Secondly, associations 
between olfactory hallucinations and age, biological (substance and 
alcohol use), social (self-reported severe, stressful life events), and 
emotional factors (self-reported symptoms of depression and anxiety) 
were investigated. Finally, the experience of olfactory hallucinations in 
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population between 18-96 years of age were randomly selected by the 
Central Bureau of Statistics in Norway and were invited to take part in 
the present study. Inclusion criteria were that they were (1) born, raised, 
and currently living in Norway and (2) able to speak Norwegian. In-
dividuals were asked to complete an extended version (Laroi, Marc-
zewski, & Van der Linden, 2004; Laroi & van der Linden, 2005) of the 
Launay-Slade Hallucinations Scale (Launay & Slade, 1981), the Hospital 
Anxiety and Depression Scale (HADS) (Zigmond & Snaith, 1983) as well 
as questions on demographics. Of the 8000 invited individuals, eleven 
refused to participate and 169 could not be reached. Of the remaining 
7820 individuals, 2533 completed the entire questionnaire (and of these 
2533, 2500 answered the question regarding olfactory hallucinations). 
The study was approved by the Regional Committee for Medical 
Research Ethics in Central Norway (REK Central) and executed ac-
cording to the Code of Ethics of the World Medical Association (Decla-
ration of Helsinki). All participants gave their informed consent prior to 
inclusion in the study. 
2.2. Launay-Slade Hallucinations Scale 
Assessment of hallucinations was based on a Norwegian translation 
of an extended version of the Launay–Slade Hallucinations Scale (Laroi 
et al., 2004). Compared to the original version (Launay & Slade, 1981), 
additional items assessing hallucinations in other modalities (visual, 
tactile, olfactory) were included. Olfactory hallucinations were assessed 
with the statement “I have experienced a particular odor even though 
there was nothing there”. Response categories were “certainly does not 
apply to me”, “possibly does not apply to me”, “uncertain”, “possibly 
applies to me” or “certainly applies to me”. Since existing studies base 
their analyses on a “yes/no” response format and we aimed to replicate 
such findings, the category “certainly applies to me” was taken as an 
indicator of olfactory hallucinations. We wanted to be sure that that 
participants actually had experienced an olfactory hallucination. Prev-
alence rates and all subsequent analyses are based on this category. 
2.3. Depression and Anxiety 
The Hospital Anxiety and Depression Scale (HADS) is a fourteen-item 
questionnaire that assesses self-reported symptoms of anxiety (7 items) 
and depression (7 items) (Zigmond & Snaith, 1983). Each item is rated 
on a four-point Likert scale, generating a total score ranging from 0 to 21 
for each subscale, with higher scores indicating more self-reported 
symptoms of depression and anxiety. A cut-off point of > 7 indicative 
of anxiety or depression for either individual subscale, was applied in 
the analyses (Bjelland, Dahl, Haug, & Neckelmann, 2002). 
2.4. Statistical methods 
Descriptive statistics were used to examine group characteristics 
with regard to sex, age, and health factors. The prevalence of olfactory 
hallucinations was estimated using separate logistic regression analysis, 
including the 95% confidence interval (95% CI) for the odds ratio. 
Factors established in the literature to be associated with hallucinations 
in any modality in non-clinical groups and available in the questionnaire 
consisted of information on socio-demographic data (age, sex, educa-
tional level), self-reported symptoms of anxiety and depression, self- 
reported mental health, experience of severe life events (i.e., experi-
ence of danger/accident; bullying/humiliation) and use of illicit drugs. 
In a second step, we included significant variables into a multivariate 
logistic regression model, entering one variable at a time. When vari-
ables no longer had a statistically significant association, they were 
excluded. This variable selection method for building logistic regression 
models invalidates the use of p-values due to multiple testing. The p- 
values from the final model do not reflect that each covariate has already 
been tested in univariate regression, and in the stepwise selection pro-
cedure. Therefore, we chose to report regression results as odds ratios 
(OR) with a 95% CI. Analyses were performed using SPSS. 
3. Results 
In the sample, 4.2% (n = 106, CI 3.5-5.1) of individuals reported the 
experience of being certain of their experience of olfactory hallucina-
tions. This number was the basis for subsequent analyses. One-hundred 
and forty-nine (6%, 95% CI 5.1-6.9) reported that they possibly expe-
rienced olfactory hallucinations. The frequency distributions of de-
mographic characteristics for individuals reporting and not reporting 
olfactory hallucinations are summarized in Table 1. 
The largest age group in the study consisted of individuals 60 years of 
age and older (28.7%). To investigate age-effects, the sample was 
divided into five age groups. Individuals 60 years and older were least 
likely to report olfactory hallucinations (13.2%, n = 14). The odds of 
reporting olfactory hallucinations in the youngest age group was more 
than four times higher compared to individuals 60 years of age and older 
(OR 4.8, 95% CI 2.4-9.2). The sample contained 54.5% women. Analyses 
revealed that women reported olfactory hallucinations more often than 
men (5.7% vs. 2.5%; OR 2.3, 95% CI 1.5 -3.6). See Table 2 for prevalence 
rates of olfactory hallucinations by age group and sex. 
The largest proportion of the sample had up to 10 years of education 
(39.9%), 35.7% had 10-14 years and 24% at least 15 years of education. 
Comparing levels of education and occurrence of olfactory hallucina-
tions showed that individuals with 11-14 years of education reported 
olfactory hallucinations significantly more often compared to those with 
at least 15 years of education (OR 2.1, 95% CI 1.2 – 3.6). 
The frequency distribution of health-related factors potentially 
associated with olfactory hallucinations and corresponding prevalence 
rates are shown in Table 3. Of the sample, 11.4% reported poor/fair 
mental health, 47.4% reported good and 41.1% excellent health. Of the 
individuals reporting olfactory hallucinations, 26.9% reported fair/poor 
mental health compared to 26% indicating excellent and 47% good 
mental health. The chance of reporting olfactory hallucinations in in-
dividuals with fair/poor health was significantly higher than in those 
individuals reporting excellent health (OR 4.0, 95% CI 2.3 – 6.9). 
About 8% of individuals reporting symptoms of depression (HADS 
depression score > 7) and more than 10% of the individuals reporting 
symptoms of anxiety (HADS anxiety score > 7) reported olfactory hal-
lucinations compared to 3.8% with HADS depression score ≤ 7 and 2.8% 
with HADS anxiety score ≤ 7 (OR depression 2.2 (95% CI 1.3 - 3.8) and 
OR anxiety 3.9 (95% CI 2.5 – 5.9)). 
Of the sample, 15.8% (n = 393) reported having experienced 
danger/accident while 32.9% (n = 829) reported having experienced 
bullying/humiliation. The chance of reporting olfactory hallucinations 
in these groups was significantly higher when reporting the experience 
of danger/accident (OR 2.5, 95% CI 1.7 – 3.9) and when reporting for 
the experience of bullying/humiliation (OR 3.7, 95% CI 2.4 – 5.5) as 
compared to individuals not having experienced such severe life events. 
Approximately 14% of the sample reported having used illicit drugs. 
Of the individuals experiencing olfactory hallucinations, 27.4% indi-
cated the use of illicit drugs. The chance of reporting olfactory halluci-
nations in the individuals reporting drug use was significantly higher 
(OR 2.4, 95% CI 1.5 – 3.7) compared to those not having used illicit 
drugs but experiencing olfactory hallucinations. 
Regarding alcohol use, 8.7% of the sample indicated no alcohol use, 
69.5% reported a frequency of 1-4 monthly, and 21.8% reported a fre-
quency of two or more times weekly. Of the individuals reporting ol-
factory hallucinations, the highest percentage indicated alcohol use 1-4 
times monthly. The likelihood of olfactory hallucinations decreased with 
an increased use of alcohol (1-4 times monthly: OR 0.6, 95% CI 0.3-1.1) 
and two or more times weekly (OR 0.4, 95% CI 0.2-0.8). 
Table 4 shows the results of the multivariate logistic regression 
analysis. There are main effects of sex and age but no interaction be-
tween these factors. Being female increased the likelihood of olfactory 
hallucinations significantly (OR 2.3, 95% CI 1.5 – 3.8). The model 
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showed further that when both factors sex and age were included in the 
model, not all categories were significant and significant differences 
were only found between the oldest and the youngest age group (OR 3.4, 
95% CI 1.7 -6.9). The increasing OR (from 1.4 to 3.4) indicated, how-
ever, an age trend. Self-reported anxiety and severe life events remained 
in the model indicating that there was a higher likelihood of reporting 
olfactory hallucinations associated with being bullied/humiliated (OR 
2.3, 95% CI 1.5 – 3.6) and having experienced danger (OR 2.7, 95% CI 
1.7 – 4.4). None of the other factors from the univariate regression 
models became significant. Table 4 shows OR and p-values for the as-
sociation of olfactory hallucinations with variables from the multivar-
iate regression model. 
3.1. Olfactory hallucinations in combination with hallucinations in other 
modalities 
Of the 4.2% participants who reported olfactory hallucinations, 44% 
(n = 47) reported solely olfactory hallucinations. For only one other 
modality, approximately 1.2% (n = 29) reported having only experi-
enced auditory hallucinations, 1.5% (n = 38) visual hallucinations and 
1.1% (n = 28) tactile hallucinations. Forty-two individuals (1.7%) re-
ported hallucinations in two modalities, 1.2% (n = 30) in three and 0.5% 
(n = 12) in all four modalities. The combinations of hallucinations from 
all modalities are shown in Table 5. Of the individuals reporting hallu-
cinations in two modalities, 57% reported olfactory hallucinations, of 
those reporting hallucinations in three modalities, 77% included olfac-
tory hallucinations. Olfactory hallucinations were the most often 
occurring in combination with tactile hallucinations (75%). 
4. Discussion 
The present study investigated the prevalence of olfactory halluci-
nations in a large population-based Norwegian sample, factors associ-
ated with these and their occurrence in combination with hallucinations 
in other sensory modalities. The results revealed a prevalence of 4.2% in 
the sample, with younger individuals and women reporting olfactory 
hallucinations most frequently. Olfactory hallucinations were associated 
with symptoms of anxiety as well as with having experienced severe life- 
events. Approximately 44% of individuals reported solely olfactory 
hallucinations while the remaining experienced olfactory hallucinations 
in combination with hallucinations in other modalities. 
The prevalence rate for olfactory hallucinations of 4.2% is lower in 
this population compared to earlier studies that report 6-6.5% in the 
large population-based samples (Bainbridge et al., 2018; Rawal et al., 
2016). These differences become even larger when we apply the 
age-range of 40 years as the lower age-limit (3.4%) as was the case in 
those studies. A possible explanation would be varying assessment for-
mats and response categories. All studies were alike in using a single 
item question but differed in using interviews (Bainbridge et al., 2018; 
Rawal et al., 2016) versus a questionnaire (our study). Furthermore, 
response categories differed between “yes/no” (Bainbridge et al., 2018; 
Rawal et al., 2016) to five response categories (our study) of which 
“certainly applies to me” was applied to calculate the above prevalence 
rate. The prevalence rate in our study would have increased to 10.2% if 
we had combined the categories “possibly applies to me” and “certainly 
applies to me”. This number would clearly have exceeded earlier re-
ports. Yet, as initially reasoned, the decision on the strictest category 
seemed most appropriate to address the topic since data derived from a 
single item addressing (a) rather specific, retrospective experience(s), 
(b) possibly dating back a long time, and/or (c) not indicating a specific 
time frame (Bainbridge et al. and Rawal et al. asked about the past 12 
months). By applying the strict category, we may have missed partici-
pants with a tendency to never answer the most extreme values in a 
questionnaire and thus the prevalence rate reported here may be 
underestimated. We therefore followed the advice of a reviewer and 
re-analyzed the data combining the two answer categories (“possibly 
applies to me” and certainly applies to me). The results did not change 
the reported findings (see Supplement). 
The significant age and sex differences corroborate and extend 
earlier findings (Bainbridge et al., 2018; Ohayon, 2000; Rawal et al., 
2016). Increasing age is associated with reduced occurrence of olfactory 
hallucinations (Bainbridge et al., 2018). Although Sjolund and col-
leagues (2017) did not corroborate an age-related decrease of olfactory 
hallucinations, this seems to relate to the age-range included in their 
sample (60-90 years), where differences may not be as large as from 
younger to older age. In the olfactory literature, an age-related increase 
in olfactory dysfunction is well-known, in particular for qualitative 
functions such as identification ability and sensitivity (Doty & Kamath, 
Table 1 
Frequency distribution of demographic characteristics and olfactory hallucinations in a Norwegian population sample and results form separate logistic regression 
models with Odds Ratio (OR) and corresponding 95% confidence interval (CI).    
Olfactory hallucinations reported     




Possibly applies to me(n =
149) 
Certainly applies to me(n =
106) 
Prevalence OH^, %(95% 
CI) 
OR (CI) 
Age       
below 30 years 322 (12.9) 265 (11.8) 29 (19.5) 28 (26.4) 8.7 (5.9 - 12.3) 4.8 (2.4 - 9.2) 
30-39 years 408 (16.3) 359 (16.0) 31 (20.8) 18 (17.0) 4.4 (2.6 - 6.9) 2.3 (1.1 - 4.7) 
40-49 years 520 (20.8) 464 (20.7) 29 (19.5) 27 (25.5) 5.2 (3.4 - 7.5) 2.8 (1.4 - 5.3) 
50-59 years 533 (21.3) 481 (21.4) 33 (22.1) 19 (17.9) 3.6 (2.2 - 5.5) 1.9 (0.9 - 3.7) 
60 and older 717 (28.7) 676 (30.1) 27 (18.1) 14 (13.2) 2.0 (1.1 - 3.3) 1 [Reference] 
Sex       
Female 1360 (45.6) 1185 (52.8) 98 (65.8) 77 (72.6) 5.7 (4.5 - 7.0) 2.3 (1.5 - 3.6) 
Male 1140 (54.5) 1060 (47.2) 51 (34.2) 29 (27.3) 2.5 (1.7 - 3.6) 1 [Reference] 
Education       
up to 10 years 994 (39.9) 894 (40.0) 62 (41.6) 38 (36.2) 3.8 (2.7 - 5.2) 1.4 (0.8 - 2.5) 
11-14 years 889 (35.7) 777 (34.7) 62 (41.6) 50 (47.6) 5.6 (4.2 - 7.3) 2.1 (1.2 - 3.6) 
15 years and 
more 
607 (24.4) 565 (25.3) 25 (16.8) 17 (16.2) 2.8 (1.6 - 4.4) 1 [Reference]  
* might vary depending on missing data 
^ Based on category “Certainly applies to me” 
Table 2 
Prevalence of olfactory hallucinations by age group and sex with 95% Confi-
dence Intervals (95% CI)   
< 30 years 30-39 years 40-49 years 50-59 
years 
60 + years 
Women 9.9 (6.1 - 
14.8) 
6.1 (3.4 - 
10.0) 
6.8 (4.2 - 
10.4) 
4.8 (2.6 - 
7.9) 
2.6 (1.2 - 
4.9) 
Men 6.7 (2.9 - 
12.8) 
2.2 (0.6 - 
5.6) 
3.1 (1.2 - 
6.2) 
2.1 (0.7 - 
4.8) 
1.3 (0.4 - 
3.1)  
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2014). The decrease in qualitative dysfunction seems to go in the 
opposite direction. In the somatic literature, including chemosensory 
samples from ear, nose and throat clinics, olfactory hallucinations are 
often (but not always) associated with quantitative olfactory loss (Bra-
merson et al., 2007; Reden et al., 2007). In studies including patients 
with schizophrenia or individuals from the general population, olfactory 
hallucinations do not seem to be related to impaired odor identification 
(Bainbridge et al., 2018; Hudry, Saoud, D’Amato, Dalery, & Royet, 
2002; Moberg et al., 1999; Sjolund et al., 2017). 
Inconsistent findings may in part originate from different causes for 
olfactory hallucinations that are not yet completely understood. For 
example, both peripheral and central causes of olfactory hallucinations 
have been described (Frasnelli, Landis, et al., 2004; Saltagi, Rabbani, 
Ting, & Higgins, 2018). Peripheral causes related to dysfunction at the 
level of olfactory neurons and receptors, in turn leading to inappropriate 
representations of olfactory stimuli (D. A. Leopold et al., 1991; Saltagi 
et al., 2018). Peripheral causes, for instance, may be more prevalent in 
patients with olfactory dysfunction. Central causes refer to damage of 
the cortical olfactory pathway and structures such as the amygdala and 
orbitofrontal areas (Bowman, Kording, & Gottfried, 2012; Fjaeldstad 
et al., 2017; Lotsch & Hummel, 2019). These may be more likely to be 
found in healthy individuals. In population-based samples like in the 
present study, the origins of olfactory hallucinations have remained 
elusive and may have different underlying causes. 
Previous studies have demonstrated that females perform better than 
males on quantitative olfactory tasks and that younger individuals 
outperform older (Doty & Kamath, 2014). Our findings show that fe-
males and younger individuals report olfactory hallucinations more 
often than males and older individuals, respectively. This seems to 
support the suggestion that sensitivity for odors may contribute to a 
higher predisposition for olfactory hallucinations (Sjolund et al., 2017). 
In that smell experiences can be more elusive than other sensory expe-
riences, particularly vague perceptions may be more vulnerable to 
misinterpretations. 
The finding that olfactory hallucinations most often occur in in-
dividuals below the age of 30 years is new and thus a novel contribution. 
There is still scarce data on olfactory hallucinations in younger adults 
from the general population. Ohayon’s (2000) study included in-
dividuals from age 15 years but did not differentiate between 
age-groups. The age effect should be replicated, and its implications 
should be investigated in future studies. There is some indication that 
Table 3 
Prevalence of olfactory hallucinations by health factors in a Norwegian popu-
lation sample 18 years and older and results from separate logistic regression 
models with Odds Ratio (OR) and corresponding 95% confidence interval (CI). * 
might vary depedning on missing data (comment to the editor - I am not able to 
include this footnote as in Table 1.    
OH 
reported    
Participants no. 







Mental health     
Excellent 1023 (41.1) 27 (26.0) 2.6 (1.7 - 3.8) 1 
[Reference] 
Good 1184 (47.5) 49 (47.1) 4.1 (3.1 - 5.4) 1.6 (1.0 - 
2.6) 
Fair/poor 284 (11.4) 28 (26.9) 9.9 (6.7 - 
13.9) 
4.0 (2.3 - 
6.9) 









241 (9.7) 19 (18.3) 7.9 (4.8 - 
12.0) 
2.2 (1.3 - 
3.8) 
Anxiety (HADS 
sum ≤ 7) 
2028 (81.5) 57 (54.3) 2.8 (2.1 - 3.6) 1 
[Reference] 
Anxiety (HADS 
sum > 7) 
461(18.5) 48 (45.7) 10.4 (7.8 - 
13.6) 
3.9 (2.5 - 
5.9) 
Severe life 
events     
No experience of 
danger/ 
accident 





393 (15.8) 33 (31.1) 8.4 (5.9 - 
11.6) 









820 (32.9) 66 (62.9) 8.0 (6.3 - 
10.1) 
3.7 (2.4 - 
5.5) 
Use of illicit 
drugs     
No 2142 (85.7) 77 (72.6) 3.6 (2.8 - 4.5) 1 
[Reference] 
Yes 358 (14.3) 29 (27.4) 8.1 (5.5 -11.4) 2.4 (1.5 - 
3.7) 
Alcohole use 
frequency     




1-4 monthly 1729 (69.5) 75 (71.4) 4.3 (3.4 - 5.4) 0.6 (0.3 - 
1.1) 
2 or more times 
weekly 
543 (21.8) 15 (14.3) 2.8 (1.6 - 4.5) 0.4 (0.2 
-0.8)  
Table 4 
Multivariate regression model and odd ratios with remaining variables for OHs 
and associated factors in a Norwegian population bases sample   
OR (95% CI) p OR (95% CI) 
Sex    
Male 1 [Reference]   
Female 2.3 (1.5 -3.8) < 0.01  
Age    
60 and older 1 [Reference]  1 [Reference] 
50-59 years 1.4 (0.7 - 2.8) 0.38 1.83 (0.9 - 3.4) 
40-49 years 1.9 (1.0 - 3.8) 0.05 2.45 (1.4 - 4.4) 
30-39 years 1.9 (0.9 - 4.0) 0.09 2.77 (1.4 - 5.3) 
below 30 years 3.4 (1.7 - 6.9) < 0.01 3.39 (2.1 - 7.2) 
Self-reported    
Anxiety (HADS sum ≤ 7) 1 [Reference]  1 [Reference] 
Anxiety (HADS sum > 7) 2.2(1.4 - 3.4) < 0.01 2.38 (1.5 - 3.7) 
Severe life events    
No exprerience of bullying/ 
humiliation 
1 [Reference]  1 [Reference] 
Bullying/humiliation 2.3 (1.5 - 3.6) < 0.01 2.4 (1.5 - 3.7) 
No experience of danger/accident 1 [Reference]  1 [Reference] 
Experience of danger/accident 2.7 (1.7- 4.4) < 0.01 2.45 (1.6- 4.0)  
Table 5 
Occurrence of OHs and in combination with hallucinations in other 
modalities  
Hallucinations in one modality 142 (5.7%) 
Olfactory 47 (1.9%) 
Auditory 29 (1.2%) 
Visual 38 (1.5%) 
Tactile 28 (1.1%) 
Hallucinations in two modalities 42 (1.7%) 
Olfactory and tactile 13 (0.5%) 
Olfactory and auditory 1 (0.0%) 
Olfactory and visual 10 (0.4%) 
Auditory and visual 5 (0.2%) 
Auditory and tactile 3 (0.1%) 
Visual and tactile 10 (0.4%) 
Hallucinations in three modalities 30 (1.2%) 
Olfactory, tactile, and auditory 6 (0.2%) 
Olfactory, tactile, and visual 13 (0.5%) 
Olfactory, auditory, and visual 4 (0.2%) 
Auditory, visual, and tactile 7(0.3%) 
Hallucinations in four modalities 12 (0.5%)  
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olfactory hallucinations are associated with an earlier onset of psychotic 
illness in psychosis-prone individuals (Kwapil et al., 1996). Yet, devel-
opmental studies investigating hallucinations in younger individuals in 
other modalities, in particular auditory and visual modalities, have 
shown that these can be transient phenomena during healthy develop-
ment (Jardri et al., 2014; Maijer et al., 2019). Linscott and van Os (2013) 
concluded that psychotic experiences (including hallucinations) are 
transient and remitted in 80% in the general population, while 7% may 
develop a psychotic disorder. They reported further that stressful and 
traumatic events were significantly associated with psychotic experi-
ences. This is for the first time supported in our findings by showing that 
anxiety and stressful life-events remained significant predictors of ol-
factory hallucinations in the multivariate model. Anxiety has been 
shown to have predictive value for auditory verbal hallucination pre-
disposition in non-clinical individuals (Allen et al., 2005) and has been 
shown to have predictive value for the triggering and maintenance of 
hallucinations in clinical populations (Freeman & Garety, 2003). Addi-
tionally, the experience of trauma/stressful life events can contribute to 
heightened anxiety (Freeman & Fowler, 2009). So far, findings indicate 
that anxiety may modulate basic olfactory perception in that normal 
individuals with high anxiety levels demonstrate an attentional bias and 
hypersensitivity in olfactory perception. They detect and process odors 
faster compared to individuals with low anxiety levels (Krusemark & Li, 
2012; La Buissonniere-Ariza, Lepore, Kojok, & Frasnelli, 2013). Never-
theless, the findings suggest that these individuals who experience ol-
factory hallucinations may have less functioning and may even be more 
apt to develop psychopathology. 
However, there is still a gap that needs to be investigated between 
olfactory hallucinations and hypersensitivity since there is no clear 
indication that odor detection sensitivity is impaired in psychiatric pa-
tients despite the presence of olfactory hallucinations. It may therefore 
be important to include cognitive processes such as reasoning and 
memory to deepen our understanding of potential processes that un-
derlie olfactory hallucinations. 
Our data do not allow any conclusion concerning the direction of the 
reported associations, although it seems plausible to assume that ol-
factory hallucinations and anxiety may occur after a severe/stressful 
event. Odor memory is known to be long-lasting and significantly 
associated with autobiographical experiences (Engen, 1973; Sullivan, 
Landers, Yeaman, & Wilson, 2000; Willander & Larsson, 2006). Odors 
are in particular maintained in autobiographical memory when contents 
are important or emotionally charged. Individuals with post-traumatic 
stress disorder (PTSD) report that trauma-related odors are strong re-
minders of past events and are related to olfactory hallucinations (Cor-
tese, Leslie, & Uhde, 2015; Vermetten & Bremner, 2003). Additionally, 
autobiographical connotations in olfactory hallucinations have been 
reported in schizophrenic patients (Stevenson et al., 2011) and normal 
elderly individuals (Sjolund et al., 2017). Yet, one must keep in mind 
that being bullying/humiliated or other stressful life events, as reported 
by individuals in our sample, may not match the emotionally charged 
experiences of war veterans. Secondly, models which state that auditory 
and visual hallucinations may arise from misattributions of visual and 
auditory imagery or from involuntary memories are somewhat less 
relevant for olfactory hallucinations in that olfactory images are hard to 
generate (Crowder & Schab, 1995; Engen, 1991; Stevenson & Case, 
2005). Explicit analyses of the association between olfactory halluci-
nations and odor imaging ability in schizophrenic patients showed that 
one-third reported that olfactory hallucinations reminded them of an 
odor experience in the past (Stevenson et al., 2011). Yet, Stevenson and 
colleagues (2011) could not confirm a relationship between olfactory 
hallucinations and odor imagery ability, and they failed to observe 
contextual triggers for olfactory hallucinations. Our data do not provide 
information on whether the content of the olfactory hallucinations was 
related to autobiographical memories and stressful life-events. 
More than half of the individuals reporting olfactory hallucinations 
indicated that they experienced hallucinations in other modalities as 
well. This finding is not new and previous findings have shown signifi-
cant correlations between hallucinations in different modalities within 
the same individual (Laroi & van der Linden, 2005; Preti et al., 2014). It 
has been suggested that there may be a general factor increasing the 
proneness to hallucinations and that hallucinations in individual mo-
dalities may be sufficient to lead to individual sensory contributions and 
symptom differences (Mitchell et al., 2017). Our data supports this 
multidimensionality and the need for more detailed assessment of in-
dividuals hallucinations which is critical to further understand these 
phenomena. The association between olfactory hallucinations and in 
particular tactile hallucinations has also been emphasized in patient 
studies (Lewandowski et al., 2009; Mueser, Bellack, & Brady, 1990; 
Stevenson et al., 2011). A recurring suggestion for this observation is 
that sniffing is a tactile experience that is used to adjust perceived odor 
intensity (Frasnelli, Heilmann, & Hummel, 2004; Teghtsoonian, Teght-
soonian, Berglund, & Berglund, 1978). Sniffing induces neural activity 
in olfactory processing areas of the brain (Sobel et al., 1998), even if no 
odor is present. Stevenson et al. (2011) suggest that individuals expe-
riencing tactile and olfactory hallucinations “experience sensations of 
sniffing in the absence of genuine sniffing (i.e., hallucinatory sniffs), leading 
to olfactory cortical activation and an olfactory hallucination” (Stevenson 
et al., 2001; page 326). This may also apply to our participants. 
The present study has several limitations. Only 32% of the 
approached individuals responded to the invitation to participate in the 
general study. This despite the fact that a reminder was sent to all the 
8,000 individuals 6 weeks after the initial invitation (for more detail 
regarding this, see Kråkvik et al., 2015). Thus, it was not possible to 
carry out analyses on these individuals as they did not wish to partici-
pate in the study and therefore no data exists for them. We can only 
speculate about the relatively low participation rate and the conse-
quences for the representativeness of the sample of those who actually 
participated. It is possible that individuals who were more prone to 
hallucinations were also more likely to participate than those who were 
less likely to have experienced hallucinations before. This could have led 
to higher endorsement rates and a larger proportion of individuals 
reporting olfactory hallucinations in particular and hallucinations in 
general. Secondly, we relied on self-reported information on psychiatric 
or somatic symptoms from the participants, which may have impacted 
our results. Self-reported status of olfactory function has been shown to 
be somewhat unreliable and biased. We argue that there are no other 
ways to assess qualitative olfactory function and that we addressed this 
issue by applying the strictest category for olfactory hallucinations in 
our analyses. Likewise, we only included results from self-reported 
symptoms of anxiety, which is not a clinical diagnosis. However, our 
results contribute to the existing literature by showing that olfactory 
hallucinations are associated with emotional symptoms triggering 
distress and potentially reducing quality of life. They highlight that ol-
factory function should be taken into account and that these symptoms 
should be taken more seriously. Future studies on olfactory hallucina-
tions should encompass detailed and comprehensive assessments that 
include dimensions such as specific time frames, frequency, duration, 
quality, and intensity (Table 6). 
Furthermore, quantitative assessment and possible autobiographic 
memories and the individuals’ reasoning around these experiences in 
addition to medical, social and biological factors need to be included in 
future studies. Another important aspect would be to assess the impli-
cation and impact of these experiences on daily life (e.g., distressing, 
unnoticed). 
5. Conclusion 
In sum, our findings add to the existing literature by showing that 
olfactory hallucinations occur more in young individuals and are asso-
ciated with stressful life events and anxiety. The underlying reasons are 
unknown but several explanations are feasible. It is likely that in-
dividuals with olfactory hallucinations in our study constitute a 
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heterogeneous group. Nevertheless, regardless of the specific underlying 
reasons for olfactory hallucinations in individuals, there seems to be 
enough evidence that olfactory hallucinations should be taken seriously 
and, when present, should be further investigated, given the increasing 
recognition that olfactory function is an important factor for well-being 
and quality of life. 
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